We don’t just make molecules. We engineer scalable, regulatory-grade solutions from lab to launch.
FDA, EMA, NMPA, and ICH-compliant synthesis and documentation packages.
Oncology, CNS, hormonal, and rare disease APIs are our specialty.
Proprietary eco-efficient reactions — including single-step biosynthesis, solvent recovery, and energy-efficient systems.
In-house QC and impurity profiling using NMR, MS, IR, HPLC, LC-MS, and stability testing.
Agile pilot batches, process optimization, and transfer to full CDMO scale-up when needed.
🧱 Route Design & Feasibility Studies
🧪 Small-Scale Synthesis (mg–100g)
🧪 Pilot Batch Production (100g–2kg)
🧪 Scale-Up to Commercial Quantities
We understand regulatory. Every API we synthesize comes with full documentation support:
“From research support to submission-ready data — we synthesize APIs with the end in mind.”
“From research support to submission-ready data — we synthesize APIs with the end in mind.”
“From research support to submission-ready data — we synthesize APIs with the end in mind.”
“From research support to submission-ready data — we synthesize APIs with the end in mind.”
“From research support to submission-ready data — we synthesize APIs with the end in mind.”
“From research support to submission-ready data — we synthesize APIs with the end in mind.”
API: Anthracycline analog
Result: 40x reduction in process waste via biosynthesis
Delivered: 3 kg GMP-batch under exclusive contract (Fresenius Kabi)
API: Custom intermediate for enzyme therapy
Timeline: 8 weeks from inquiry to validated pilot batch
Delivered: CoA, MS, and batch-specific ICH impurity report
Whether you’re sourcing a rare oncology intermediate or scaling a complex impurity — Chemigran is your reliable, sustainable synthesis partner.